HI
AMLX icon

Harbour Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History

Harbour Investments’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62K Hold
90
– – ﹤0.01% 4085
2026
Q1 		$1.25K Hold
90
– – ﹤0.01% 4045
2025
Q4 		$1.09K Hold
90
– – ﹤0.01% 3443
2025
Q3 		$1.22K Hold
90
– – ﹤0.01% 3386
2025
Q2 		$577 Hold
90
– – ﹤0.01% 3349
2025
Q1 		$319 Hold
90
– – ﹤0.01% 3388
2024
Q4 		$340 Buy
+90
New +$424 ﹤0.01% 3324

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Harbour Investments's AMLX Position: Q2 2026 in Review

Harbour Investments held its Amylyx Pharmaceuticals (AMLX) position steady in Q2 2026 at 90 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

Harbour Investments first reported a position in AMLX in Q4 2024 and has held it in 7 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Harbour Investments held 90 shares of Amylyx Pharmaceuticals worth $1.62K as of Q2 2026.
  • Harbour Investments left its Amylyx Pharmaceuticals share count unchanged in Q2 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4085 holding.
  • Harbour Investments first reported a position in Amylyx Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.